alpha-cyano-4-hydroxycinnamate has been researched along with Multiple Myeloma in 1 studies
alpha-cyano-4-hydroxycinnamate: specific inhibitor of pyruvate transport in rat liver mitochondria & human erythrocytes; structure
Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanson, DJ | 1 |
| Nakamura, S | 1 |
| Amachi, R | 1 |
| Hiasa, M | 1 |
| Oda, A | 1 |
| Tsuji, D | 1 |
| Itoh, K | 1 |
| Harada, T | 1 |
| Horikawa, K | 1 |
| Teramachi, J | 1 |
| Miki, H | 1 |
| Matsumoto, T | 1 |
| Abe, M | 1 |
1 other study available for alpha-cyano-4-hydroxycinnamate and Multiple Myeloma
| Article | Year |
|---|---|
Effective impairment of myeloma cells and their progenitors by blockade of monocarboxylate transportation.
Topics: Cell Death; Cell Line, Tumor; Coumaric Acids; Gene Knockdown Techniques; Humans; Hydrogen-Ion Concen | 2015 |